| Keywords: |
cancer survival; child; cancer recurrence; multimodality cancer therapy; antineoplastic agents; cancer radiotherapy; combined modality therapy; cytarabine; methotrexate; brain radiation; follow-up studies; antineoplastic combined chemotherapy protocols; radiotherapy dosage; recurrence; editorial; thiotepa; central nervous system; time factors; central nervous system neoplasms; meningeal neoplasms; remission induction; quinone derivative; hydrocortisone; second cancer; bone marrow transplantation; testis; mercaptopurine; cerebrospinal fluid cytology; epipodophyllotoxin derivative; leukemia, lymphocytic, acute; 4 hydroperoxycyclophosphamide; leukemic meningitis; prognosis; human; priority journal; brain leukemia
|
